Hypoxia-inducible factor-1α expression and angiogenesis in gastrointestinal stromal tumor of the stomach

Oncology Reports

Volumn 10, Issue 4, 2003, Pages 797-802

  Takahashi, Ryoji ^a   Tanaka, Shinji ^b   Hiyama, Toru ^a   Ito, Masanori ^b   Kitadai, Yasuhiko ^a   Sumii, Masaharu ^a   Haruma, Ken ^c   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

GIST; HIF 1 ; MVD; Prognosis; VEGF

Indexed keywords

HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; TRANSCRIPTION FACTOR; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PROGNOSIS; STOMACH TUMOR; STROMA CELL; SURVIVAL RATE; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STOMACH NEOPLASMS; STROMAL CELLS; SURVIVAL RATE; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0142175222     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.4.797     Document Type: Article

References (46)

1. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 46: 467-473, 1986.
2. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
3. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997. (Pubitemid 27076453)
4. Shibuya M: Role of VEGF-FLT receptor system in normal and tumor angiogenesis. Adv Cancer Res 67: 281-316, 1995.
5. Dvorak HF, Brown LF, Detmar M and Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
6. Klagsbrun M and D'Amore PA: Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7: 259-270, 1995.
7. Takahashi R, Tanaka S, Kitadai Y, Sumii M, Yoshihara M, Haruma K and Chayama K: Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology 2002 (In press).
8. Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M, Kuwabara M, Yoshida K, Hirai T, Kajiyama G and Tahara E: Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res 4: 2195-2200, 1998. (Pubitemid 28415667)
9. Yamamoto S, Yasui W, Kitadai Y, Yokozaki H, Haruma K, Kajiyama G and Tahara E: Expression of vascular endothelial growth factor in human gastric carcinomas. Pathol Int 48: 499-506, 1998. (Pubitemid 28341085)
10. Christiane JB, Wenbiao L, Darren WD, Raymond MS, David JM, Michael RW, Corazon DB, Daniel JH and Lee ME: Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murin model of colorectal carcinoma liver metastases. Cancer 89: 488-499, 2000.
11. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
12. Wang GL, Jiang BH, Rue EA and Semenza GL: Hypoxia-inducible factor-1 is basic-helix-loop-helix-PAS heterodimer regulated by cellular 0-2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
13. Crews ST: Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev 12: 607-620, 1998.
14. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY and Semenza GL: Cellular and developmental control of O-2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12: 149-162, 1998. (Pubitemid 28060446)
15. Tian H, Hammer RE, Matsumoto AM, Russell DW and McKnight SL: The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12: 3320-3324, 1998. (Pubitemid 28520979)
16. Bunn HF and Polyton RO: Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76: 839-885, 1996. (Pubitemid 26286080)
17. Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578, 1999.
18. Salceda S and Caro J: Hypoxia-inducible factor 1 alpha-(HIF-1 alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J Biol Chem 272: 22642-22647, 1997. (Pubitemid 27386079)
19. Huang LE, Gu J, Schau M and Bunn HF: Regulation of hypoxia-inducible factor-1 alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95: 7987-7992, 1998.
20. Maxwell PH, Wiesener M, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ: The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275, 1999. (Pubitemid 29246458)
21. Wenger RH and Gassmann M: Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378: 609-616, 1997. (Pubitemid 27361853)
22. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60: 7075-7083, 2000. (Pubitemid 32059187)
23. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM and Johnson RS: Hypoxia-inducible factor-1 alpha is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015, 2000. (Pubitemid 30636574)
24. Jiang BH, Agani F, Passaniti A and Semenza GL: V-SRC induces expression of hypoxia-inducible factor-1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57: 5328-5335, 1997. (Pubitemid 27516371)
25. Ryan HE, Lo J and Johnson RS: HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17: 3005-3015, 1998. (Pubitemid 28254373)
26. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D and Keshet E: Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation, and tumor angiogenesis. Nature 394: 485-490, 1998. (Pubitemid 28373960)
27. Kung AL, Wang S, Klco JM, Kaelin WG and Livingston DM: Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 6: 1335-1340, 2000. (Pubitemid 32001016)
28. Folkman J: What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 82: 4-6, 1990.
29. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEG F gene. Nature 380: 439-442, 1996. (Pubitemid 26102720)
30. Hashimoto M, Ohsawa M, Ohnishi A, Naka N, Hirota S, Kitarnura Y and Aozaki K: Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab Invest 73: 859-863, 1995. (Pubitemid 26002346)
31. Plate KH, Breier G and Weich HA: Expression implications for induction and inhibition of tumor angiogenesis. Cancer Res 5: 4575-4580, 1995.
32. Shima DT, Kuroki M, Deutsch U, Ng YS, Adamis AP and D'Amore PA: The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem 271: 3877-3883, 1996.
33. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996. (Pubitemid 26272112)
34. Fang J, Yan L, Shing Y and Moses MA: HIF-1-alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res 61: 5731-5735, 2001. (Pubitemid 32769087)
35. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Issacs WB, Semenza GL and Simons JW: Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res 59: 5830-5835 1999.
36. Evans SM, Hahn SM, Magarelli DP and Koch CJ: Hypoxic heterogeneity in human tumors. Am J Clin Oncol 24: 467-472 2001.
37. Wiesener MS, Munchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jurgensen JS, Gruber G, Maxwell PH, Loning SA, Frei U, Maher ER, Grone HJ and Eckardt KU: Constitutive activation of hypoxia-inducible gene related to overexpression of hypoxia-inducible factor-la in clear cell renal carcinoma. Cancer Res 61: 5215-5222, 2001. (Pubitemid 32681556)
38. Shimamoto T, Haruma K, Sumii K, Kajiyama G and Tahara E: Flow cytometric DNA analysis of gastric smooth muscle tumors. Cancer 70: 2031-2034, 1992.
39. Shimamoto T, Haruma K, Tanaka S, Todo H, Yoshihara M, Sumii K and Kajiyama G: Usefulness of nucleolar organizer region staining in gastric myogenic tumors: correlation with ploidy by DNA flow cytometry. Oncology 50: 52-56, 1993. (Pubitemid 23041112)
40. Amin MB, Ma CK, Linden MD, Kubus JJ and Zarbo RJ: Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors, correlation with mitotic count and clinical outcome. Am J Clin Pathol 100: 428-432, 1993. (Pubitemid 23296510)
41. Chang MS, Choe G, Kim WH and Kim YI: Small intestinal stromal tumors: a clinicopathologic study of 31 tumors. Pathol Int 48: 341-347, 1998. (Pubitemid 28355157)
42. Hillemanns M, Pasold S, Bottcher K and Hofler H: Prognostic factors of gastrointestinal stromal tumors of the stomach. Verh Dusch Ges Pathol 82: 261-266, 1998.
43. Ma CK, De Peralta MN, Amin MB, Linden MD, De Kovich AA, Kubus JJ and Zarbo RJ: Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferating antigens. Am J Clin Pathol 108: 641-651, 1997. (Pubitemid 27506230)
44. Carrillo R, Candia A, Rodriguez-Peralto JL and Caz V: Prognosis significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 28: 160-165, 1997. (Pubitemid 27069180)
45. Sakurai S, Fukayama M, Kaizaki Y, Saito K, Kanazawa K, Kitamura M, Iwasaki Y, Hishima T and Koike M: Telomerase activity in gastrointestinal stromal tumors. Cancer 83: 2060-2066, 1998. (Pubitemid 28525386)
46. Nishida T and Hirota S: Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 15: 1293-1301, 2000.